Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
346.00    1.40 (0.41%)
Bid:
345.00
Ask:
345.20
Spread: 0.20 (0.058%)
Market Cap: £2.53b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Acquisition

16 Sep 2019 16:13

RNS Number : 5023M
TP ICAP PLC
16 September 2019
 

16 September 2019

 

TP ICAP acquires ClearCompress

Expansion into innovative compression services

 

TP ICAP plc ("TP ICAP" or "the Company") today announces that it has acquired ClearCompress Limited ("ClearCompress"), a provider of innovative, algorithm-based, light-touch compression services in cleared and uncleared derivatives that assist clients to achieve cost efficiencies and capital reduction.

 

TP ICAP and ClearCompress started collaborating in 2017. At that time, ClearCompress contributed development and algorithm expertise and TP ICAP contributed access to clients and support infrastructure. The parties deepened their relationship in March 2019 when TP ICAP agreed to provide funding of £500,000 and the benefit of its regulated status to ClearCompress. The parties have now agreed to formalise their relationship with the acquisition of ClearCompress by TP ICAP. The key team members of ClearCompress, including David Hill, the CEO, will remain with the business and continue to expand its client base and service range.

 

The sellers of ClearCompress are the founders, early-stage investors and management team. The consideration for the acquisition is £750,000 in cash to be paid over 2 years, and performance-related payments for the 6 years starting 1 September 2019 until 31 August 2025 based on the revenues of the business, payable annually in cash or shares at the discretion of TP ICAP.

 

The gross assets of ClearCompress at 31 January 2019 were £88,152 and the business reported a loss before tax of £346,606 for the year ended 31 January 2019.

 

Nicolas Breteau, CEO of TP ICAP, said, "The acquisition of ClearCompress is in line with our strategy to broaden our customer service offering. The compression runs we have conducted demonstrate excellent outcomes for our clients. We are delighted to welcome this innovative company with its expertise in algo-driven capital optimisation solutions to our group and we are excited to move forward and grow the business together."

 

David Hill, CEO of ClearCompress, said, "As ClearCompress enters the next phase in its development, we are looking forward to being a part of the TP ICAP Group which will enable us to accelerate our client reach, develop new products and expand internationally. Our partnership with TP ICAP and the solutions we deliver have been well received by clients and we are enthusiastic and confident about what more we can do in the future."

 

ENDS

 

Enquiries:

 

TP ICAP:

Analysts and Investors

Al Alevizakos

Alevizos.Alevizakos@tpicap.com

+44 (0) 203 933 3040

 

Media

William Baldwin-Charles

William.Baldwin-Charles@tpicap.com 

+44 (0) 20 7200 7124

 

About TPICAP

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world. We operate from offices in 31 countries, supporting award-winning brokers with market-leading technology.

www.tpicap.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQCKADDPBKDBCD
Date   Source Headline
17th May 20235:05 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
13th Apr 202312:30 pmRNSHolding(s) in Company
5th Apr 20233:00 pmRNSDirector/PDMR Shareholding
4th Apr 202311:00 amRNSNotice of AGM and Committee Membership Changes
3rd Apr 20235:05 pmRNSDirector/PDMR Shareholding
29th Mar 20234:00 pmRNSHolding(s) in Company
23rd Mar 202311:00 amRNSDirector/PDMR Shareholding
22nd Mar 202311:00 amRNS2022 Annual Report and Accounts
14th Mar 20237:00 amRNSTP ICAP Group PLC - Final Results
8th Feb 20234:19 pmRNSChanges to Senior Independent Director
13th Dec 202210:00 amRNSHolding(s) in Company
6th Dec 20225:15 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSTrading Statement
27th Oct 20225:30 pmRNSHolding(s) in Company
25th Oct 20225:50 pmRNSHolding(s) in Company
13th Sep 20225:32 pmRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
28th Jul 20225:22 pmRNSResult of External Audit Tender
30th Jun 20225:44 pmRNSHolding(s) in Company
27th May 20223:30 pmRNSDirector/PDMR Shareholding
11th May 20226:01 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.